About this episode

This episode provides an evidence-based breakdown of Thymosin Alpha-1, focusing on its immune mechanisms and research findings.

An evidence-based breakdown of Thymosin Alpha-1 (TA-1) covering immune mechanisms, preclinical research, human clinical trials, safety data, and ongoing studies in infection, sepsis, and cancer.

More episodes of Today's discussion on unraveling BPC 157 Peptide

• SS-31 and the Architecture of Mitochondrial Medicine · March 9, 2026 · 20 min
• Snap-8 Science: A Deep Dive into Peptide Power · February 12, 2026 · 14 min
• FST-344: Scientific Foundations and Therapeutic Potential · February 2, 2026 · 17 min
• Tesofensine: The Neurochemical Frontier of Weight Management · January 26, 2026 · 15 min
• TB500 more updated information for possible healing · January 20, 2026 · 17 min
• Tesamorelin from bench to bedside FDA approval · January 5, 2026 · 12 min

Explore listener stats, chart rankings, contacts and more on the Today's discussion on unraveling BPC 157 Peptide podcast page.